lansoprazole has been researched along with Kidney Diseases in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A significant, although weak, relationship existed between creatinine clearance (CLCR) and area under the plasma concentration versus time curve (AUC) and terminal disposition half-life (t1/2), calculated with total concentration data." | 1.30 | Lansoprazole pharmacokinetics in subjects with various degrees of kidney function. ( Cavanaugh, JM; Karol, MD; Machinist, JM, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiramatsu, SI | 1 |
| Ikemura, K | 1 |
| Fujisawa, Y | 1 |
| Iwamoto, T | 1 |
| Okuda, M | 1 |
| Karol, MD | 1 |
| Machinist, JM | 1 |
| Cavanaugh, JM | 1 |
2 other studies available for lansoprazole and Kidney Diseases
| Article | Year |
|---|---|
Concomitant lansoprazole ameliorates cisplatin-induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats.
Topics: Animals; Antineoplastic Agents; Cisplatin; HEK293 Cells; Humans; Kidney; Kidney Diseases; Lansoprazo | 2020 |
Lansoprazole pharmacokinetics in subjects with various degrees of kidney function.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Area Under Curve; Case-Control Studies; Half-L | 1997 |